Modeling the transport of drugs eluted from stents: physical phenomena driving drug distribution in the arterial wall

[1]  Elazer R Edelman,et al.  Stent elution rate determines drug deposition and receptor-mediated effects. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[2]  E. Omerovic,et al.  Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). , 2012, European heart journal.

[3]  F. Eberli,et al.  Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents: Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE Trial , 2011, Circulation.

[4]  S. McKee,et al.  Modelling drug-eluting stents. , 2011, Mathematical medicine and biology : a journal of the IMA.

[5]  Giuseppe Pontrelli,et al.  A multi-layer porous wall model for coronary drug-eluting stents , 2010 .

[6]  P. Serruys,et al.  Coronary stents: current status. , 2010, Journal of the American College of Cardiology.

[7]  I. Berger,et al.  Paclitaxel-induced arterial wall toxicity and inflammation: tissue uptake in various dose densities in a minipig model. , 2010, Journal of vascular and interventional radiology : JVIR.

[8]  Juan F Granada,et al.  Drug-coated balloons for the prevention of vascular restenosis. , 2010, Circulation.

[9]  Francesco Migliavacca,et al.  Drug release from coronary eluting stents: A multidomain approach. , 2010, Journal of biomechanics.

[10]  Charles A. Taylor,et al.  Drug transport in artery walls: A sequential porohyperelastic-transport approach , 2009, Computer methods in biomechanics and biomedical engineering.

[11]  A. Tzafriri,et al.  Diffusion‐limited binding explains binary dose response for local arterial and tumour drug delivery , 2009, Cell proliferation.

[12]  T. Hilder,et al.  Probability of encapsulation of paclitaxel and doxorubicin into carbon nanotubes , 2008 .

[13]  G Dubini,et al.  Modelling drug elution from stents: effects of reversible binding in the vascular wall and degradable polymeric matrix , 2008, Computer methods in biomechanics and biomedical engineering.

[14]  CHRISTIAN VERGARA,et al.  Multiscale Boundary Conditions for Drug Release from Cardiovascular Stents , 2008, Multiscale Model. Simul..

[15]  Charles A. Taylor,et al.  The three-dimensional micro- and nanostructure of the aortic medial lamellar unit measured using 3D confocal and electron microscopy imaging. , 2008, Matrix Biology.

[16]  K. Vafai,et al.  Critical assessment of arterial transport models , 2008 .

[17]  Elazer R Edelman,et al.  Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Isam Faik,et al.  Effects of diffusion coefficients and struts apposition using numerical simulations for drug eluting coronary stents. , 2007, Journal of biomechanical engineering.

[19]  Say Chye Joachim Loo,et al.  Effects of controlled-released sirolimus from polymer matrices on human coronary artery smooth muscle cells , 2007, Journal of biomaterials science. Polymer edition.

[20]  Masato Nakamura,et al.  Role of stent design and coatings on restenosis and thrombosis. , 2006, Advanced drug delivery reviews.

[21]  J. Barry,et al.  The Taxus drug-eluting stent: a new paradigm in controlled drug delivery. , 2006, Advanced drug delivery reviews.

[22]  Kambiz Vafai,et al.  A coupling model for macromolecule transport in a stenosed arterial wall , 2006 .

[23]  Kambiz Vafai,et al.  Modeling of low-density lipoprotein (LDL) transport in the artery—effects of hypertension , 2006 .

[24]  Carol S. Woodward,et al.  Enabling New Flexibility in the SUNDIALS Suite of Nonlinear and Differential/Algebraic Equation Solvers , 2020, ACM Trans. Math. Softw..

[25]  A. Tzafriri,et al.  Strut Position, Blood Flow, and Drug Deposition: Implications for Single and Overlapping Drug-Eluting Stents , 2005, Circulation.

[26]  J. S. Suri,et al.  Plaque Imaging: Pixel to Molecular Level , 2005 .

[27]  K Perktold,et al.  Mathematical and numerical models for transfer of low-density lipoproteins through the arterial walls: a new methodology for the model set up with applications to the study of disturbed lumenal flow. , 2005, Journal of biomechanics.

[28]  Abdul I. Barakat,et al.  Computational Study of Fluid Mechanical Disturbance Induced by Endovascular Stents , 2005, Annals of Biomedical Engineering.

[29]  John F LaDisa,et al.  Stent design properties and deployment ratio influence indexes of wall shear stress: a three-dimensional computational fluid dynamics investigation within a normal artery. , 2004, Journal of applied physiology.

[30]  E. Edelman,et al.  Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Paolo Zunino,et al.  Multidimensional Pharmacokinetic Models Applied to the Design of Drug-Eluting Stents , 2004 .

[32]  Elazer R Edelman,et al.  Arterial Ultrastructure Influences Transport of Locally Delivered Drugs , 2002, Circulation research.

[33]  E. Edelman,et al.  Carrier proteins determine local pharmacokinetics and arterial distribution of paclitaxel. , 2001, Journal of pharmaceutical sciences.

[34]  E. Edelman,et al.  Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery , 2001, Circulation.

[35]  Karl Perktold,et al.  Computational Modeling of Macromolecule Transport in the Arterial Wall , 2001 .

[36]  S. Whitaker.  The method of volume averaging , 1998 .

[37]  S. Weinbaum,et al.  A fiber matrix model for the growth of macromolecular leakage spots in the arterial intima. , 1994, Journal of biomechanical engineering.

[38]  S. Weinbaum,et al.  Effect of cell turnover and leaky junctions on arterial macromolecular transport. , 1985, The American journal of physiology.

[39]  D. Levitt.  General continuum analysis of transport through pores. I. Proof of Onsager's reciprocity postulate for uniform pore. , 1975, Biophysical journal.

[40]  Alfio Quarteroni,et al.  Cardiovascular mathematics : modeling and simulation of the circulatory system , 2009 .

[41]  Rosaire Mongrain,et al.  Numerical modeling of coronary drug eluting stents. , 2005, Studies in health technology and informatics.

[42]  O. Kedem,et al.  Commentary on 'Thermodynamic Analysis of the Permeability of Biological Membranes to Non-Electrolytes'. , 1989, Biochimica et biophysica acta.

[43]  Stephen Whitaker,et al.  Transient diffusion, adsorption and reaction in porous catalysts: the reaction controlled, quasi-steady catalytic surface , 1986 .

[44]  E. M. Renkin,et al.  Mechanics and thermodynamics of transcapillary exchange , 1984 .

[45]  N. Simionescu,et al.  The Cardiovascular System , 1983 .

[46]  A. Katchalsky,et al.  Thermodynamic analysis of the permeability of biological membranes to non-electrolytes. , 1958, Biochimica et biophysica acta.